Home  /  Medical Apps  / CINV Risk Test
CINV Risk Test Application icon

CINV Risk Test 1.2

10.5 MB / 1+ Downloads / Rating 4.0 - 2 reviews


See previous versions

CINV Risk Test, developed and published by Helsinn Healthcare S.A., has released its latest version, 1.2, on 2023-01-26. This app falls under the Medical category on the Google Play Store and has achieved over 100 installs. It currently holds an overall rating of 4.0, based on 2 reviews.

CINV Risk Test APK available on this page is compatible with all Android devices that meet the required specifications (Android 2.2+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.energycom.nausea

Updated: 2 years ago

Developer Name: Helsinn Healthcare S.A.

Category: Medical

New features: Show more

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing CINV Risk Test on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

App Rating

4.0
Total 2 reviews

Previous Versions

CINV Risk Test 1.2
2023-01-26 / 10.5 MB / Android 2.2+

About this app

Chemotherapy-induced nausea and vomiting (CINV) continues to be a major concern in cancer treatment. In fact, despite advances in oncological therapies and supportive care, more than 50% of patients undergoing emetogenic chemotherapy still experienceacute and delayed CINV.
The immediate impact of CINV on Quality of Life (QoL) is obvious. Unfortunately, healthcare providers often underestimate the incidence of CINV in cancer patients and the importance of an effective management of this condition.

The risk of developing CINV depends upon patient- and treatment-related factors. Patient-related risk factors include age <50 years, female gender, low chronic alcohol intake, prior episodes of CINV, susceptibility to motion sickness, and anxiety. With respect to treatment-related risk factors, each chemotherapy agent has an intrinsic propensity to cause CINV, the intensity of which depends on the class and dose of drug administered.

The “CINV Risk Test”, available with this application, is an user-friendly tool which helps the correct evaluation of each patient’srelative risk of developing CINV. Some practical hints for the patients in managing nausea and vomiting are included in the tool.

New features

Update content

App Permissions

Allows applications to access information about Wi-Fi networks.
Allows applications to access information about networks.
Allows an application to write to external storage.
Allows applications to open network sockets.
Allows an application to read from external storage.